Vera G. Subrakova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vera G. Subrakova has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adelya A. Galiakberova
Pirogov Russian National Research Medical University, Moscow, Russia
1 shared publication - Anastasia Alekseevna Korobeynikova
Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences
1 shared publication - Anna A. Khozyainova
Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 634009 Tomsk, Russia
1 shared publication - Daria Ivanovna Zhigalina
Research Institute of Medical Genetics, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia
1 shared publication - Dm Loos
Cancer Research Institute — Tomsk National Research Medical Center
1 shared publication - Elena Evgenievna Kopantseva
Research Institute of Molecular and Cellular Medicine, Peoples’ Friendship University of Russia (RUDN University), 115093 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
Single-cell transcriptomics reveals a conserved embryonic progenitor in different human cancers
Cellular plasticity, a critical feature of embryonic development, is often reactivated in cancer, enabling tumor cells to acquire stem-like properties and facilitate uncontrolled growth. This study compares cellular plasticity in cancer and early human development by integrating single-cell data from three cancers and embryoid bodies. The analysis identifies a shared, highly proliferative progenitor-like state, driven by an E2F-TFDP transcriptional axis and enriched in key cell-cycle regulators UBE2C , TOP2A , BIRC5 , and NUSAP1 . Functionally linked to cell-cycle progression and DNA repair, this state acts as a lineage hub within tumors. Spatial transcriptomics revealed that this state is enriched in lung adenocarcinoma and in lung tissue with basal cell hyperplasia, a potential precursor to squamous cell carcinoma. Validation across eight cancer types demonstrates a prevalence of this program in tumors versus normal cells. Collectively, these findings define a conserved mechanism of tumor plasticity with potential for early detection and targeted therapy. Abstract Figure:
Open AccessSingle-cell transcriptomics reveals a conserved embryonic progenitor in different human cancers
Cellular plasticity, a critical feature of embryonic development, is often reactivated in cancer, enabling tumor cells to acquire stem-like properties and facilitate uncontrolled growth. This study compares cellular plasticity in cancer and early human development by integrating single-cell data from three cancers and embryoid bodies. The analysis identifies a shared, highly proliferative progenitor-like state, driven by an E2F-TFDP transcriptional axis and enriched in key cell-cycle regulators UBE2C , TOP2A , BIRC5 , and NUSAP1 . Functionally linked to cell-cycle progression and DNA repair, this state acts as a lineage hub within tumors. Spatial transcriptomics revealed that this state is enriched in lung adenocarcinoma and in lung tissue with basal cell hyperplasia, a potential precursor to squamous cell carcinoma. Validation across eight cancer types demonstrates a prevalence of this program in tumors versus normal cells. Collectively, these findings define a conserved mechanism of tumor plasticity with potential for early detection and targeted therapy. Abstract Figure: